IMMEDIATELY LOADED ZYGOMATIC IMPLANTS VERSUS CONVENTIONAL DENTAL IMPLANTS IN AUGMENTED ATROPHIC MAXILLAE: THREE-YEAR POST-LOADING RESULTS FROM A MULTICENTRE RANDOMISED CONTROLLED TRIAL

PURPOSE. To compare the clinical outcomes of immediately loaded cross-arch maxillary prostheses supported by zygomatic implants versus conventional implants placed in augmented bone. MATERIALS AND METHODS. Seventy-one edentulous patients with severely atrophic maxillae not having sufficient bone volumes for placing dental implants, or when it was possible to place only two implants of minimal diameter 3.5 mm and length of 8 mm in the frontal area and there was less than 4 mm of bone height subantrally were randomi-sed according to a parallel-group design to receive either zygomatic implants (35 patien-ts) to be loaded immediately or xenograft followed, after 6 months of graft consolidation, by placement of six to eight conventional dental implants submerged for 4 months (36 patients). Outcome measures were: prosthesis, implant and augmentation failures, any complica-tions, quality of life (OHIP-14), number of days with totally or partially impaired activity, time to function, and number of dental visits, as assessed by independent assessors. Patients were followed up to 3 years after loading. RESULTS. Eight patients from the augmentation group dropped out versus three from the zygomatic group. One augmentation procedure failed. Eight prostheses could not be fitted or failed in the augmentation group versus two prostheses in the zygomatic group, the difference being not statistically significant (difference in proportions = 18.18%; 95% CI: 1.44 to 34.91; P = 0.082). Nine patients in the augmentation group lost 42 implants versus three patients who lost six zygomatic implants, the difference being not statistically significant (difference in proportions = 21.65%; 95% CI: 2.02 to 41.20; P = 0.052). Sixteen augmented patients were affected by 30 complications versus 29 zygomatic patients (55 complications), the difference being statistically significant (difference in proportions =-30.87 %; 95% CI:-51.88 to-9.86; P = 0.007). The 3-year OHIP-14 score was 4.11±7.27 in augmented patients and 4.51±6.23 in zygomatic patients, with no statistically significant differences between groups (mean difference = 0.40; 95% CI:-2.80 to 3.61; P = 0.624). Both groups had significantly improved OHIP-14 scores from before rehabilitation (P < 0.01 for both augmentation and zygomatic patients). Days of total infirmity were, on average, 7.42±3.17 in the augmentation group and 7.17±1.96 in the zygomatic group, the difference not being statistically significant (mean difference =-0.25; 95% CI:-1.52 to 1.02; P = 0.692). Days of partial infirmity were on average, 14.24±4.64 in the augmented group and 12.17±3.82 in the zygomatic group, the difference being statistically significant (mean difference =-2.07; 95% CI:-4.12 to-0.02; P = 0.048). The mean number of days to functional prosthesis fitting were 444.32±207.86 in augmentation patients and 1.34±2.27 in zygomatic patients, the difference being statistically significant (mean difference =-442.98; 95% CI:-513.10 to-372.86; P < 0.001). The average number of dental appointments was 23.00±11.80 for augmentation patients and 20.05±6.23 for zygomatic patients, the difference not being statistically significant (mean difference =-2.94; 95% CI:-7.62 to 1.74; P = 0.213).